CN Patent

CN101677961A — 包含苯并咪唑-7-羧酸酯衍生物和ph控制剂的固体药物组合物

Assigned to Haisen Bio Pharmaceutical Co ltd · Expires 2010-03-24 · 16y expired

What this patent protects

本发明提供固体药物组合物，其包含具有血管紧张素II受体拮抗作用并在说明书中定义的化合物(I)和pH控制剂，该组合物在化合物(I)的稳定性和溶出性方面优异。

USPTO Abstract

本发明提供固体药物组合物，其包含具有血管紧张素II受体拮抗作用并在说明书中定义的化合物(I)和pH控制剂，该组合物在化合物(I)的稳定性和溶出性方面优异。

Drugs covered by this patent

azilsartan-kamedoxomil (AZILSARTAN KAMEDOXOMIL)

Patent Metadata

Patent number: CN101677961A
Jurisdiction: CN
Classification: —
Expires: 2010-03-24
Drug substance claim: No
Drug product claim: No
Assignee: Haisen Bio Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.